pan-elr + CXC Chemokine Antibody

A technology of antibodies and chemoattractant proteins, applied in the direction of antibodies, anti-cytokines/lymphokines/interferon immunoglobulins, anti-tumor drugs, etc. Disclosing issues such as antibodies

Active Publication Date: 2022-05-24
ELI LILLY & CO
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the publication does not demonstrate that the antibody binds tightly to GCP-2 (CXCL6) and does not mention binding to NAP-2 (CXCL7)
[0006] However, no antibodies capable of binding and neutralizing all 7 human ELR+ CXC chemokines have been published

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • pan-elr <sup>+</sup> CXC Chemokine Antibody
  • pan-elr <sup>+</sup> CXC Chemokine Antibody
  • pan-elr <sup>+</sup> CXC Chemokine Antibody

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0040] Expression and production of antibodies

[0041] Antibodies for use in the present invention can be expressed and purified as follows. NS0 cells were transfected with expression vectors comprising the DNA sequences of SEQ ID NO: 5 (encoding the heavy chain polypeptide of SEQ ID NO: 1) and SEQ ID NO: 6 (encoding the light chain polypeptide of SEQ ID NO: 3). The antibody obtained from this expression vector is "Antibody 1".

[0042]Additionally, NS0 cells were transfected with expression vectors comprising the DNA sequences of SEQ ID NO: 17 (encoding the heavy chain polypeptide of SEQ ID NO: 13) and SEQ ID NO: 18 (encoding the light chain polypeptide of SEQ ID NO: 15). The antibody obtained from this expression vector is "Antibody 2".

[0043] For Antibody 1 or Antibody 2, transfection pools were plated at low density to allow growth of nearly monoclonal stable expressing cells. Master wells were screened for antibody expression and then scaled up for production in se...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Provides Pan‑ELR that specifically binds 7 human ELR+CXC chemokines + CXC chemokine antibody. The antibodies of the invention are useful in the treatment of various inflammatory / autoimmune diseases, such as inflammatory bowel disease (IBD), psoriasis, and pustulosis palmoplantar; and cancers, such as renal or ovarian cancer.

Description

[0001] This application is a Chinese patent application 201480013248.X "Pan-ELR" on March 5, 2014 + CXC Chemokine Antibodies" divisional application. technical field [0002] The present invention relates to antibodies directed against ELR+ CXC chemokines and their use in the treatment of diseases whose pathogenesis is mediated by ELR+ CXC chemokines. Background technique [0003] ELR+ CXC chemokines (so called because members of this chemokine family all have an E-L-R amino acid motif next to their CXC motif) play important roles in a variety of pathogenesis, including neutrophil recruitment to inflammation and blood vessels Migration of generative sites. Neutrophils contribute to the pathogenesis of several acute and chronic inflammatory / autoimmune diseases, such as inflammatory bowel disease (IBD), psoriasis, and palmoplantar pustulosis. ELR+ CXC chemokines also play key roles in tumorigenesis and tumor metastasis. These chemokines are highly expressed in tumors. In ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/24A61K39/395A61P17/06A61P17/00
CPCC07K16/24A61K2039/505C07K2317/34C07K2317/76C07K2317/33C07K2317/92A61P1/00A61P17/00A61P17/06A61P35/00
Inventor C.B.贝德勒K.K.基克利B.A.斯特里夫勒D.R.维彻尔J.S.博伊尔斯
Owner ELI LILLY & CO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap